Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagata, K.
Right arrow Articles by Nakagawa, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagata, K.
Right arrow Articles by Nakagawa, M.
(Chest. 2003;124:2293-2301.)
© 2003 American College of Chest Physicians

Effect of Inhaled NG-Nitro-L-Arginine Methyl Ester on Candida-Induced Acute Lung Injury*

Kazuhiro Nagata, MD; Yoshinobu Iwasaki, MD, PhD; Yoshizumi Takemura, MD; Hidehiko Harada, MD; Ichiro Yokomura, MD, PhD; Shinji Fushiki, MD, PhD and Masao Nakagawa, MD, PhD

* From the Department of Medicine (Drs. Nagata, Iwasaki, Takemura, Harada, Yokomura, and Nakagawa), Kyoto Prefectural University of Medicine; and Department of Pathology and Applied Neurobiology (Dr. Fushiki), Research Institute for Neurologic Diseases and Geriatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Correspondence to: Kazuhiro Nagata, MD, Second Department of Medicine, Kyoto Prefectural University of Medicine, 465, Kawaramachi Hirokoji, Kamigyo-ku, Kyoto 602, Japan; e-mail: nagata{at}koto.kpu-m.ac.jp

Study objectives: Nitric oxide (NO) and peroxynitrite play a crucial role in acute lung injury (ALI). Whether NO synthase (NOS) inhibition is beneficial in the treatment of lung injury remains controversial. The objective of this study was to test the hypothesis that local inhibition of NOS in the lung reduces lung injury.

Design: We developed a model of Candida-induced ALI in the mouse by IV injection of Candida albicans. To evaluate the effect of NOS inhibitor, mice were pretreated by inhalation of saline solution or NG-nitro-L-arginine methyl ester (L-NAME) before induction of Candida-induced ALI.

Measurements and results: After inhalation of 1 mM aerosolized L-NAME, nitrite-nitrate concentrations in BAL fluid (BALF) were significantly lower at 24 h and 48 h than those in mice treated with C albicans alone. Tumor necrosis factor-{alpha}, interleukin-1ß, and macrophage inflammatory protein-2 concentrations in lung homogenates, measured by enzyme-linked immunosorbent assay, and neutrophil counts in BALF were decreased by inhalation of L-NAME (n = 6 per group). Immunohistochemical analysis of inducible NOS (iNOS) and nitrotyrosine, a major product of protein nitration by peroxynitrite, revealed that alveolar macrophages and alveolar epithelial cells were positive for both substances in Candida-induced ALI. Inhalation of L-NAME markedly suppressed iNOS protein expression and nitrotyrosine production. Histologic evidence of lung injury decreased and survival improved after inhalation of L-NAME.

Conclusions: We conclude that NO might play a crucial role in the pathogenesis of Candida-induced ALI, and such injury might be reduced by local inhibition of NOS. Our findings suggest that inhalation of L-NAME is beneficial in the treatment of Candida-induced ALI.

Key Words: acute lung injury • Candida • NG-nitro-L-arginine methyl ester • nitric oxide






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.